Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients

International Journal of Oncology

Volumn 35, Issue 1, 2009, Pages 115-120

  Ranieri, Girolamo ^a,c   Ammendola, Michele ^a   Patruno, Rosa ^b   Celano, Giuseppe ^b   Zito, Francesco Alfredo ^c   Montemurro, Severino ^c   Rella, Addolorata ^d   Di Lecce, Valentina ^c   Gadaleta, Cosmo Damiano ^a   De Sarro, Giovanni Battista ^a   Ribatti, Domenico ^d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^d UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Breast cancer; Endothelial area; Mast cells; Microvascular density; Tryptase

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; SERINE PROTEINASE; TRYPTASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENSITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MAST CELL; MASTECTOMY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN SECRETION; SEGMENTAL MASTECTOMY; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; TRYPTASES;

EID: 67649422130     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000319     Document Type: Article

References (41)

1. Fisseler-Eckhoff A, Rothstein D and Muller KM: Neovascularisation in hyperplastic, metaplastic and potentially preneoplastic lesions of the bronchial mucosa. Virchows Arch 429: 95-100, 1996.
2. Folkman J: Tumor angiogenesis and tissue factor. Nat Med 2: 209-215, 1996.
3. Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R and Cheresh DA: Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4: 2625-2634, 1998.
4. Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P and Ribatti D: Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 13: 1845-1857, 2006.
5. Patruno R, Arpaia N, Gadaleta CD, Passantino L, Zizzo N, Misino A, Lucarelli NM, Catino A, Valerio P, Ribatti D and Ranieri G: VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med (In press).
6. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB and Evan GI: Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13: 1211-1218, 2007.
7. Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L and Dammacco F: Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79: 451-455, 1999.
8. Norrby K: Mast cells and angiogenesis. APMIS 110: 355-371, 2002.
9. Kankkunen JP, Harvima IT and Naukkarinen A: Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72: 385-388, 1997.
10. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG and Gruber BL: Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 99: 2691-2700, 1997.
11. Somasundaran P, Ren G, Nagar H, Kraemer D, Mendoza L, Michael LH Caughey GH, Entman ML and Frangogiannis NG: Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol 205: 102-111, 2005.
12. Polverini PF: How the extracellular matrix and macrophages contribute to angiogenesis-dependent disease. Eur J Cancer 32A: 2430-2437, 1996.
13. Dethlefsen SM, Matsuura N and Zetter BR: Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 14: 395-408, 1994.
14. Ranieri G, Passantino L, Patruno R, Passantino G, Jirillo F, Catino A, Mattioli V, Gadaleta C and Ribatti D: The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol Rep 10: 1189-1193, 2003.
15. Ranieri G, Labriola A, Achille G, Florio G, Zito AF, Grammatica L and Paradiso A: Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol 21: 1317-1323, 2002.
16. Yano H, Kinuta M, Tateishi H, Nakano Y, Matsui S, Monden T, Okamura J, Sakai M and Okamoto S: Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 2: 26-32, 1999.
17. Takanami I, Takeuchi K and Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88: 2686-2692, 2000.
18. Ch'ng S, Wallis RA, Yuan L, Davis PF and Tan ST: Mast cells and cutaneous malignancies. Mod Pathol 19: 149-159, 2006.
19. Kashiwase Y, Morioka J, Inamura H, Yoshizawa Y, Usui R and Kurosawa M: Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int Arch Allergy Immunol 134: 199-205, 2004.
20. Ribatti D, Finato N, Crivellato E, Guidolin D, Longo V, Mangieri D, Nico B, Vacca A and Beltrami CA: Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology 51: 837-842, 2007.
21. Bloom HJ and Richardson WW: Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957.
22. Ranieri G, Grammatica L, Patruno R, Zito AF, Valerio P, Iacobellis S, Gadaleta C, Gasparini G and Ribatti D: A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients. J Cell Mol Med 11: 362-368, 2007.
23. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Werb Z, Caughey GH and Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-1397, 1999.
24. Nico B, Mangieri D, Crivellato E, Vacca A and Ribatti D: Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 17: 19-22, 2008.
25. Ribatti D, Nico B, Maxia C, Longo V, Murtas D, Mangieri D, Perra MT, De Giorgis M, Piras F, Crivellato E and Sirigu P: Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 11: 585-589, 2007.
26. Hallgren J, Estrada S, Karlson U, Alving K and Pejler G: Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry 40: 7342-7439, 2001.
27. Fajardo I and Pejler G: Human mast cell beta-tryptase is a gelatinase. J Immunol 171: 1493-1499, 2003.
28. Itoh Y, Sendo T and Oishi R: Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. J Pharmacol Sci 97: 14-19, 2005.
29. Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA and Steinhoff M: Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 118: 380-385, 2002.
30. 2+ -independent phospholipase A2 in bladder microvascular endothelial cells. Am J Physiol Renal Physiol 288: F714-F721, 2005.
31. Sendo T, Sumimura T, Itoh Y, Goromaru T, Aki K, Yano T, Oike M, Ito Y, Mori S, Nishibori M and Oishi R: Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cell Signal 15: 773-781, 2003.
32. Matej R, MandàKovà P, Netikovà I, Pouckovà P and Olejàr T: Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231. Physiol Res 56: 475-484, 2007.
33. Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL and Trejo J: Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66: 307-314, 2006.
34. Liu Y and Mueller BM: Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun 344: 1263-1270, 2006.
35. Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S and Sirigu P: Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33: 420-425, 2003.
36. Yodavudh S, Tangjitgamol S and Puangsa-art S: Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer. J Med Assoc Thai 91: 723-732, 2008.
37. Ibaraki T, Muramatsu M, Takai S, Jin D, Maruyama H, Orino T, Katsumata T and Miyazaki M: The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 28: 617-621, 2005.
38. Peng SH, Deng H, Yang JF, Xie PP, Li C, Li H and Feng DY: Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 11: 6521-6524, 2005.
39. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B and Senn HJ: 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol 18: 1133-1144, 2007.
40. Erba F, Fiorucci L, Pascarella S, Menegatti E, Ascenzi P and Ascoli F: Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochem Pharmacol 61: 271-276, 2001.
41. Mori S, Itoh Y, Shinohata R, Sendo T, Oishi R and Nishibori M: Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J Pharmacol Sci 92: 420-423, 2003.